Skip to content

An innovative approach for robotic-assisted laparoscopic radical prostatectomy: a single-hospital study

Pubovesical Complex-sparing Technique during Robotic-assisted Laparoscopic Radical Prostatectomy functional and oncologic outcomes report: a single-institution case series

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN10803536
Enrollment
35
Registered
2023-08-30
Start date
2019-01-01
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical skill introduction and surgical outcome report for clinically localized prostate cancer patients with specific surgical treatment Surgery

Interventions

Surgical skill introduction and surgical outcome report for patients who received pubovesical complex-sparing robotic-assisted laparoscopic radical prostatectomy.

Sponsors

Tungs' Taichung MetroHarbor Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Male patients aged over 18 years and 0.2 ng/mL 5. Prostate volume <60 mL 6. Normal preoperative continence and sexual function. Patients had to be completely continent (pad-free) and have an IIEF score =17 at baseline. Continence was defined as not using pads. Potency was defined as achieving full erection during sexual intercourse with or without using phosphodiesterase 5 inhibitors (PDE5-Is).

Exclusion criteria

Exclusion criteria: 1. Neoadjuvant hormonal therapy 2. Previous prostate, urethra, or bladder neck surgery 3. Bilateral NVBs were not preserved 4. Salvage RALP 5. Anteriorly located tumours

Design outcomes

Primary

MeasureTime frame
Erectile function measured using the International Index of Erectile Function (IIEF)-5 score preoperatively and at follow-up for at least 2 years

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

Taiwan

Contacts

Public ContactChin-Heng Lu
chinhenglu@gmail.com+886 (0)980985308

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026